Precision NextGen Oncology is a clinical research site located in Beverly Hills, California, United States 90212.
Crixeo Clinical Trials Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Precision NextGen Oncology has participated in 11 clinical trials with 9 currently active.
Therapeutic areas: Liposarcoma, Dedifferentiated, Neoplasms, Tenosynovial Giant Cell Tumor.
Sponsors: Boehringer Ingelheim, Abbisko Therapeutics Co, Ltd, Krystal Biotech, Inc..
Trust Score: 75/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Precision NextGen Oncology has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Precision NextGen Oncology has 11 clinical trials on record, with 9 currently active. Their work covers Liposarcoma, Dedifferentiated, Neoplasms, Tenosynovial Giant Cell Tumor.
Precision NextGen Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.